Apiam Animal Health Ltd
ASX:AHX
Apiam Animal Health Ltd
ASX:AHX
Price:
0.38 AUD
-2.56%
Market Closed
Updated:
May 9, 2024
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
20
Current
19.8
Median
12.6
Industry
Higher
than median
Higher
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=20
Enterprise Value
/
165.4m
EBITDA
8.3m
All Countries
| Market Cap | EV/EBITDA | ||||
|---|---|---|---|---|---|
| AU |
|
Apiam Animal Health Ltd
ASX:AHX
|
67.7m AUD | 20 | |
| US |
|
Cigna Corp
NYSE:CI
|
99.7B USD | 9.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
91.3B EUR | 9.8 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
69.7B USD | 8.6 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
17.4B USD | 12.1 | |
| DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.8B EUR | 10.1 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15.3B USD | 10.9 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.5B EUR | 6.8 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
11.3B EUR | 6.8 | |
| US |
|
DaVita Inc
NYSE:DVA
|
12.1B USD | 8.3 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -23.3 |
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
6.4
2-Years Forward
EV/EBITDA
5.9
3-Years Forward
EV/EBITDA
N/A
You don't have any saved screeners yet
